Your Best Stock

Thermo Fisher Scientific TMO

$670.67
+$5.37 (+0.81%)
Market open · Sep 24, 1:10 pm ET
After hours $665.30 0.00%
Open$661.08
Prev close$665.30
Day range$655.95 – $681.55
Volume960.7K
Market cap$247.98B
P/E (TTM)36.1
Dividend yield0.27%

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$11.99B+10.5% YoY
Operating profit$2.19B+14.0% YoY
Net profit$1.74B+7.6% YoY
Diluted EPS$4.68+9.3% YoY
Free cash flow$1.68B+51.6% YoY
Operating cash flow$2.13B

Revenue, last 8 quarters

$10.6BSep '24$11.4BDec '24$10.4BMar '25$10.9BJun '25$11.1BSep '25$12.2BDec '25$11.0BMar '26$12.0BJun '26

Net profit, last 8 quarters

$1.6BSep '24$1.8BDec '24$1.5BMar '25$1.6BJun '25$1.6BSep '25$2.0BDec '25$1.7BMar '26$1.7BJun '26

Diluted EPS by quarter

4.25Sep '244.78Dec '243.98Mar '254.28Jun '254.27Sep '255.21Dec '254.43Mar '264.68Jun '26

Free cash flow by quarter

$1.9BSep '24$2.8BDec '24$361.0MMar '25$1.1BJun '25$1.8BSep '25$3.0BDec '25$816.0MMar '26$1.7BJun '26

Annual revenue

$32.2BFY20$39.2BFY21$44.9BFY22$42.9BFY23$42.9BFY24$44.6BFY25

Profitability & balance sheet

Gross margin40.8%
Operating margin18.3%
Net margin15.0%
Return on equity13.5%
Return on assets6.5%
Return on invested capital8.2%
Current ratio1.55
Liabilities / assets53.3%
Cash & investments$4.06B
Total debt$42.55B
Net cash (debt)-$38.49B
Free cash flow / sales15.8%

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Laboratory Products and Biopharma Services$6.69B 53.3%
  • Life Sciences Solutions$2.82B 22.4%
  • Analytical Instruments$1.85B 14.7%
  • Specialty Diagnostics$1.21B 9.6%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $11.99B $11.01B $44.56B $12.22B $11.12B
Total Operating Revenue $11.99B $11.01B $44.56B $12.22B $11.12B
Cost of Revenue $7.11B $6.58B $26.32B $7.20B $6.54B
Gross Profit $4.88B $4.43B $18.24B $5.01B $4.58B
Operating Expense $2.70B $2.52B $10.13B $2.71B $2.51B
Selling and Admin Expenses $2.33B $2.18B $8.73B $2.35B $2.16B
Research & Development $364.00M $336.00M $1.40B $356.00M $346.00M
Operating Profit $2.19B $1.91B $8.11B $2.30B $2.08B
Net Non-Operating Interest Income (Expense) -$194.00M -$121.00M -$426.00M -$107.00M -$113.00M
Non-Operating Interest Income $207.00M $233.00M $993.00M $258.00M $234.00M
Non-Operating Interest Expense $401.00M $354.00M $1.42B $365.00M $347.00M
Other Income (Expense) -$67.00M -$58.00M -$374.00M -$40.00M -$137.00M
Special Income (Charges) -$98.00M -$49.00M -$362.00M -$46.00M -$135.00M
-Less:Restructuring and Mergern & Acquisition $98.00M $49.00M $362.00M $46.00M $135.00M
Other Non-Operating Income (Expenses) $31.00M -$9.00M -$25.00M -$7.00M -$2.00M
Pretax Profit $1.92B $1.73B $7.31B $2.15B $1.83B
Tax $167.00M $70.00M $547.00M $153.00M $207.00M
Earnings from Equity Interest Net of Tax -$15.00M -$8.00M -$41.00M -$32.00M $2.00M
Net Profit $1.74B $1.66B $6.72B $1.97B $1.62B
Profit from Continuing Operations $1.74B $1.66B $6.72B $1.97B $1.62B
Minority Interests $5.00M $5.00M $17.00M $6.00M $5.00M
Net Income to Parent Company $1.74B $1.65B $6.70B $1.96B $1.62B
Net Income to Common Stockholders $1.74B $1.65B $6.70B $1.96B $1.62B
Basic EPS $4.68 $4.44 $17.77 $5.22 $4.28
Diluted EPS $4.68 $4.43 $17.74 $5.21 $4.27
Dividend Per Share $0.47 $0.47 $1.72 $0.43 $0.43
Gain on Sale of Security $13.00M

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $113.17B $113.28B $110.34B $110.34B $103.02B
Total Current Assets $23.37B $22.32B $28.71B $28.71B $22.30B
Cash and Cash Equivalents & Short-Term Investments $4.06B $3.26B $10.11B $10.11B $3.55B
-Cash and Cash Equivalents $4.06B $3.25B $9.85B $9.85B $1.98B
-Short Term Investments $0.00 $2.00M $253.00M $253.00M $1.56B
Receivables $11.14B $10.89B $10.57B $10.57B $10.53B
-Accounts Receivable $9.45B $9.20B $8.90B $8.90B $8.91B
-Other Receivables $1.69B $1.68B $1.67B $1.67B $1.62B
Inventory $5.63B $5.50B $5.43B $5.43B $5.75B
Other Current Assets $2.54B $2.68B $2.61B $2.61B $2.47B
Total Non-Current Assets $89.81B $90.96B $81.64B $81.64B $80.73B
Net PPE $10.76B $10.66B $10.57B $10.57B $10.18B
Goodwill and Other Intangible Assets $73.44B $74.33B $65.20B $65.20B $65.53B
-Goodwill $54.83B $55.19B $49.36B $49.36B $49.29B
-Other Intangible Assets $18.61B $19.15B $15.84B $15.84B $16.24B
Other Non-Current Assets $5.62B $5.97B $5.87B $5.87B $5.02B
Total Liabilities $60.37B $61.22B $56.81B $56.81B $51.87B
Total Current Liabilities $15.07B $14.62B $15.19B $15.19B $14.89B
Payables $3.27B $3.34B $3.62B $3.62B $3.12B
-Accounts Payable $3.27B $3.34B $3.62B $3.62B $3.12B
Current Accrued Expenses $5.52B $5.26B $5.32B $5.32B $5.09B
Short-Term Debt and Capital Lease Obligation $3.37B $3.09B $3.53B $3.53B $3.82B
-Current Debt $3.37B $3.09B $3.53B $3.53B $3.82B
Current Deferred Liabilities $2.92B $2.93B $2.71B $2.71B $2.85B
Other Current Liabilities -$2.00M
Total Non-Current Liabilities $45.30B $46.60B $41.62B $41.62B $36.98B
Long Term Debt and Capital Lease Obligation $39.18B $40.07B $35.85B $35.85B $31.86B
-Long Term Debt $39.18B $40.07B $35.85B $35.85B $31.86B
Non-Current Deferred Liabilities $1.58B $2.11B $1.49B $1.49B $842.00M
Other Non-Current Liabilities $4.54B $4.42B $4.27B $4.27B $4.28B
Total Equity $52.81B $52.06B $53.54B $53.54B $51.15B
Stockholders' Equity $52.68B $51.93B $53.41B $53.41B $51.02B
Capital Stock $446.00M $445.00M $445.00M $445.00M $445.00M
-Common Stock $446.00M $445.00M $445.00M $445.00M $445.00M
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $18.87B $18.71B $18.56B $18.56B $18.33B
Retained Earnings $62.19B $60.63B $59.16B $59.16B $57.35B
Less: Treasury Stock $26.37B $25.36B $22.31B $22.31B $22.31B
Gains/Losses Not Affecting Retained Earnings -$2.46B -$2.50B -$2.45B -$2.45B -$2.80B
Minority Interests $128.00M $128.00M $129.00M $129.00M $136.00M
-Gross PPE $18.38B $18.38B
-Accumulated Depreciation -$7.82B -$7.82B

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $2.13B $1.19B $7.82B $3.46B $2.24B
Net cash flow from continuing operations $2.12B $1.19B $7.82B $3.46B $2.24B
Net Income from Continuing Operations $1.74B $1.66B $6.72B $1.97B $1.62B
Depreciation & Depletion & Amortization $817.00M $736.00M $2.78B $728.00M $661.00M
Deferred Tax -$208.00M -$258.00M -$639.00M $89.00M -$127.00M
Other Non-Cash Items $118.00M $87.00M $412.00M $97.00M $118.00M
Change in Working Capital -$425.00M -$1.11B -$1.77B $489.00M -$104.00M
Net cash flow from investing $164.00M -$8.96B -$4.05B $891.00M -$4.12B
Net Cash Flow from Continuing Investing Activities $165.00M -$8.96B -$4.05B $892.00M -$4.12B
Net PPE Purchase and Sale -$446.00M -$367.00M -$1.48B -$438.00M -$400.00M
Net Business Purchase and Sale $0.00 -$8.87B -$4.04B $0.00 -$4.04B
Net Investment Purchase and Sale $554.00M $332.00M $1.45B $1.33B $292.00M
Net Other Investing Changes $56.00M -$54.00M $21.00M $0.00 $22.00M
Financing Cash Flow -$1.57B $1.09B $1.80B $3.53B -$632.00M
Net Cash Flow from Continuing Financing Activities -$1.57B $1.09B $1.80B $3.53B -$632.00M
Net Issuance Payments Of Debt -$389.00M $4.22B $5.35B $3.63B $498.00M
Net Common Stock Issuance -$1.00B -$3.00B -$3.00B -$37.00M -$963.00M
Cash Dividends Paid -$175.00M -$162.00M -$636.00M -$162.00M -$163.00M
Net Other Financing Charges -$7.00M $40.00M $90.00M $91.00M -$4.00M
Ending Cash Balance $4.10B $3.28B $9.88B $9.88B $2.01B
Net Change in Cash $718.00M -$6.68B $5.57B $7.87B -$2.52B
Beginning Cash Balance $3.28B $9.88B $4.04B $2.01B $4.60B
Effect of Exchange Rate Changes $98.00M $78.00M $267.00M -$6.00M -$75.00M
Free Cash Flow $1.68B $816.00M $6.29B $2.99B $1.84B
-Change in Receivables -$426.00M
-Change in Inventory -$74.00M
-Change in Payables and Accrued Expense $421.00M
-Change In Other Working Capital -$1.69B
Scroll to Top